definiens: Licensed Producls " ) derived from the Licensed Materials ( ( defined below ), In connection with lha1licen~, [COMPANY] wishes to obtain from The National Institutes ofAllergy and Infectious Diseases ( ) ccnain information rights, This letter ( ) seL~ fonh the partie.\ ' agreement with respect to those rights, NlAID understands that [COMPANY] ( or its subJicen.<;ee ) i ~ to file and own any new IND for theLkensed Products, NJAlD acknowledges that it is the holder currently of lND No . ~B - IND-2858, ( the ), covering Bovine PIV3 candidate vaccine ] NJAIDhereby grants [COMPANY] an ellclu .,ive right of reference to the Existing IND, and any newlND filed by NlAlD with respect to the Licensed Materials, including all Raw Data(defined below ) . All Clinical Dala iIlIdResearch Results ( defined below ) of NIAll ) shallhe made available ellclusively to [COMPANY] for use in obtaining regulatory approval for thecommercialization and marketing of Licen.~ ProductJ ;, However, notlling containedwithin this Leuer Agreement shall prohibit NIAID from publishing summary data of suchRaw Data or Clinical Data and Rcscan : h Result " consistent with NIAID policy, NIAlDshall take appropriate precautions to ellSUrcthat [COMPANY] may review . cross reference or, asappropriate, Olherwi!le 0.""the RlIi.ting JND in conducting cJinicallrials within the scope ofthis Agreement and the License Agreement, and in fulfilling all the rcquircmenL ~ necessaryfor ohtaining FDA approval to market Licensed Products